Furin J, Alirol E, Allen E, Fielding K, Merle CS, et al.
2016-03-01 • International Journal of Tuberculosis and Lung Disease
2016-03-01 • International Journal of Tuberculosis and Lung Disease
Drug-resistant tuberculosis (DR-TB) is a growing public health problem, and for the first time in decades, new drugs for the treatment of this disease have been developed. These new dru...
Alirol E, Schrumpf D, Amici Heradi J, Riedel A, de Patoul C, et al.
2013-01-01 • Clinical Infectious Diseases
2013-01-01 • Clinical Infectious Diseases
BACKGROUND Existing diagnostic and treatment tools for human African trypanosomiasis (HAT) are limited. The recent development of nifurtimox-eflornithine combination therapy (NECT) h...
Chappuis F, Alirol E, d'Acremont V, Bottieau E, Yansouni CP
2013-05-01 • Clinical Microbiology and Infection
2013-05-01 • Clinical Microbiology and Infection
The recent roll-out of rapid diagnostic tests (RDTs) for malaria has highlighted the decreasing proportion of malaria-attributable illness in endemic areas. Unfortunately, once malaria i...
Kimutai R, Musa AM, Njoroge SM, Omollo R, Alves F, et al.
2017-03-01 • Clinical Drug Investigation
2017-03-01 • Clinical Drug Investigation
INTRODUCTION In 2010, WHO recommended a new first-line treatment for visceral leishmaniasis (VL) in Eastern Africa. The new treatment, a combination of intravenous (IV) or intramuscu...
